| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| Gross Profit | $0 | +100.0% |
| R&D Expense | $65K | — |
| SG&A Expense | $164K | +6.1% |
| Operating Income | -$415K | -21.6% |
| Interest Expense | $117K | -40.4% |
| Net Income | -$1.2M | +17.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | — |
| Current Assets | $625K | — |
| Total Assets | $712K | +309.3% |
| Current Liabilities | $5.2M | +35.7% |
| Stockholders' Equity | -$4.5M | -22.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.0M | -474.2% |
| Capital Expenditures | $4K | — |
| Investing Cash Flow | -$4K | — |
| Financing Cash Flow | $1.0M | +506.2% |
| Free Cash Flow | -$1.0M | -476.5% |